Hope for patients 'burdened by their ITP disease' in China after Hutchmed positive trial results 22-Aug-2023 By Liza Laws Hutchmed is planning to submit a New Drug Application (NDA) for treatment of primary immune thrombocytopenia (ITP) in China.